1	O
,	O
25	O
(	O
OH	O
)	O
2D2	O
production	O
by	O
T	B-cell_type
lymphocytes	I-cell_type
and	O
alveolar	B-cell_type
macrophages	I-cell_type
recovered	O
by	O
lavage	O
from	O
normocalcemic	O
patients	O
with	O
tuberculosis	O
.	O

To	O
compare	O
extra-renal	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
production	O
in	O
different	O
types	O
of	O
granulomatous	O
disease	O
,	O
and	O
to	O
identify	O
the	O
cell	O
types	O
responsible	O
,	O
we	O
have	O
evaluated	O
the	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D3	O
in	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
by	O
uncultured	B-cell_type
cells	I-cell_type
recovered	O
by	O
bronchoalveolar	O
lavage	O
and	O
blood	B-cell_type
mononuclear	I-cell_type
cells	I-cell_type
from	O
normocalcemic	O
patients	O
with	O
sarcoidosis	O
and	O
tuberculosis	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
was	O
produced	O
both	O
by	O
lavage	B-cell_type
cells	I-cell_type
(	O
12/12	O
tuberculosis	O
patients	O
,	O
2/6	O
sarcoidosis	O
patients	O
)	O
and	O
blood	B-cell_type
mononuclear	I-cell_type
cells	I-cell_type
(	O
3/5	O
tuberculosis	O
patients	O
,	O
0/3	O
sarcoidosis	O
patients	O
)	O
from	O
patients	O
but	O
not	O
controls	O
,	O
but	O
significantly	O
greater	O
amounts	O
were	O
produced	O
by	O
lavage	O
cells	O
from	O
tuberculosis	O
patients	O
than	O
those	O
of	O
sarcoidosis	O
patients	O
(	O
P	O
less	O
than	O
0.001	O
)	O
.	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
production	O
by	O
lavage	B-cell_type
cells	I-cell_type
from	O
tuberculosis	O
patients	O
correlated	O
with	O
the	O
number	O
of	O
CD8+	O
T	B-cell_type
lymphocytes	I-cell_type
present	O
but	O
not	O
other	O
cell	O
types	O
.	O

T	B-cell_type
lymphocytes	I-cell_type
appeared	O
to	O
be	O
an	O
important	O
source	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
production	O
,	O
since	O
purified	O
T	B-cell_type
lymphocytes	I-cell_type
from	O
all	O
patients	O
with	O
tuberculosis	O
produced	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
,	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
production	O
by	O
these	O
cells	O
correlated	O
closely	O
with	O
that	O
produced	O
by	O
unseparated	O
lavage	B-cell_type
cells	I-cell_type
.	O

Because	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
can	O
improve	O
the	O
capacity	O
of	O
macrophages	B-cell_type
to	O
kill	O
mycobacteria	O
,	O
our	O
results	O
support	O
the	O
conclusion	O
that	O
macrophage-lymphocyte	O
interactions	O
,	O
mediated	O
at	O
least	O
in	O
part	O
by	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
,	O
may	O
be	O
an	O
important	O
component	O
of	O
a	O
successful	O
antituberculous	O
immune	O
response	O
.	O

1,25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
Production	NULL
by	NULL
T	NULL
Lymphocytes	NULL
and	NULL
Alveolar	NULL
Macrophages	NULL
Recovered	NULL
by	NULL
Lavage	NULL
from	NULL
Normocalcemic	NULL
Patients	NULL
with	NULL
Tuberculosis	NULL
Jacques	NULL
Cadranel	NULL
,	NULL
*	NULL
Michele	NULL
Garabedian	NULL
,	NULL
*	NULL
Bernard	NULL
Milleron	NULL
,	NULL
``	NULL
Huguette	NULL
Guillozo	NULL
,	NULL
*	NULL
Georges	NULL
Akoun	NULL
,	NULL
!	NULL

and	NULL
Allan	NULL
J.	NULL
Hance*	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Medicale	NULL
U.82	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
Xavier	NULL
Bichat	NULL
,	NULL
*Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
UA	NULL
583-Paris	NULL
V	NULL
,	NULL
France	NULL
;	NULL
and	NULL
Hopital	NULL
Necker-Enfants	NULL
Malades	NULL
,	NULL
§Service	NULL
de	NULL
Pneumo-phisiologie	NULL
et	NULL
Réanimation	NULL
Respiratoire	NULL
,	NULL
Hopital	NULL
Tenon	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
Abstract	NULL
To	NULL
compare	NULL
extra-renal	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
production	NULL
in	NULL
different	NULL
types	NULL
of	NULL
granulomatous	NULL
disease	NULL
,	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
cell	NULL
types	NULL
responsible	NULL
,	NULL
we	NULL
have	NULL
evaluated	NULL
the	NULL
conversion	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
uncultured	NULL
cells	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
and	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
normocalcemic	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
was	NULL
produced	NULL
both	NULL
by	NULL
lavage	NULL
cells	NULL
(	NULL
12/12	NULL
tuberculosis	NULL
patients	NULL
,	NULL
2/6	NULL
sarcoidosis	NULL
patients	NULL
)	NULL
and	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
3/5	NULL
tuberculosis	NULL
patients	NULL
,	NULL
0/3	NULL
sarcoidosis	NULL
patients	NULL
)	NULL
from	NULL
patients	NULL
but	NULL
not	NULL
controls	NULL
,	NULL
but	NULL
significantly	NULL
greater	NULL
amounts	NULL
were	NULL
produced	NULL
by	NULL
lavage	NULL
cells	NULL
from	NULL
tuberculosis	NULL
patients	NULL
than	NULL
those	NULL
of	NULL
sarcoidosis	NULL
patients	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
lavage	NULL
cells	NULL
from	NULL
tuberculosis	NULL
patients	NULL
correlated	NULL
with	NULL
the	NULL
number	NULL
of	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
present	NULL
but	NULL
not	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

T	NULL
lymphocytes	NULL
appeared	NULL
to	NULL
be	NULL
an	NULL
important	NULL
source	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
,	NULL
since	NULL
purified	NULL
T	NULL
lymphocytes	NULL
from	NULL
all	NULL
patients	NULL
with	NULL
tuberculosis	NULL
produced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
production	NULL
by	NULL
these	NULL
cells	NULL
correlated	NULL
closely	NULL
with	NULL
that	NULL
produced	NULL
by	NULL
unseparated	NULL
lavage	NULL
cells	NULL
.	NULL

Because	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
improve	NULL
the	NULL
capacity	NULL
of	NULL
macrophages	NULL
to	NULL
kill	NULL
mycobacteria	NULL
,	NULL
our	NULL
results	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
macrophage-lymphocyte	NULL
interac-tions	NULL
,	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
may	NULL
be	NULL
an	NULL
important	NULL
component	NULL
of	NULL
a	NULL
successful	NULL
antituberculous	NULL
immune	NULL
response	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1990	NULL
.	NULL

85:1588-1593	NULL
.	NULL
)	NULL

vitamin	NULL
D	NULL
metabolism	NULL
«	NULL
tuberculosis	NULL
«	NULL
sarcoidosis	NULL
«	NULL
T	NULL
lymphocytes	NULL
«	NULL
alveolar	NULL
macrophages	NULL
Introduction	NULL
Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
patients	NULL
with	NULL
granulomatous	NULL
diseases	NULL
,	NULL
including	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
,	NULL
can	NULL
.	NULL

produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
at	NULL
sites	NULL
of	NULL
disease	NULL
activity	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
spontaneous	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
granulomatous	NULL
tissues	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
granulomatous	NULL
reactions	NULL
by	NULL
influencing	NULL
the	NULL
maturation	NULL
and	NULL
activity	NULL
of	NULL
immune	NULL
and	NULL
inflammatory	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
potential	NULL
importance	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
at	NULL
sites	NULL
of	NULL
granulomatous	NULL
reactions	NULL
,	NULL
several	NULL
relevant	NULL
questions	NULL
remain	NULL
unanswered	NULL
:	NULL
First	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
in	NULL
different	NULL
types	NULL
of	NULL
granulomatous	NULL
disease	NULL
has	NULL
never	NULL
been	NULL
compared	NULL
,	NULL
and	NULL
therefore	NULL
it	NULL
is	NULL
Address	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
A.	NULL
J.	NULL
Hance	NULL
,	NULL
INSERM	NULL
U.82	NULL
,	NULL
Faculté	NULL
Xavier	NULL
Bichat	NULL
,	NULL
16	NULL
,	NULL
rue	NULL
Henri	NULL
Huchard	NULL
,	NULL
75018	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
26	NULL
May	NULL
1989	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
20	NULL
October	NULL
1989	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
588/06	NULL
$	NULL
2.00	NULL
Volume	NULL
85	NULL
,	NULL
May	NULL
1990	NULL
,	NULL
1588-1593	NULL
1588	NULL
Cadranel	NULL
,	NULL
Garabedian	NULL
,	NULL
Milleron	NULL
,	NULL
Guillozo	NULL
,	NULL
Akoun	NULL
,	NULL
and	NULL
Hance	NULL
unknown	NULL
whether	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
metabolite	NULL
merely	NULL
reflects	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
granulomatous	NULL
response	NULL
,	NULL
or	NULL
whether	NULL
certain	NULL
granulomatous	NULL
reactions	NULL
are	NULL
associated	NULL
with	NULL
greater	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
.	NULL

Secondly	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
,	NULL
what	NULL
cell	NULL
types	NULL
spontaneously	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Fresh	NULL
tissue	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
or	NULL
unseparated	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
from	NULL
sites	NULL
of	NULL
granulomatous	NULL
reactions	NULL
can	NULL
spontaneously	NULL
transform	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

It	NULL
is	NULL
reasonable	NULL
to	NULL
expect	NULL
that	NULL
purified	NULL
subpopulations	NULL
of	NULL
these	NULL
cells	NULL
would	NULL
also	NULL
retain	NULL
this	NULL
capacity	NULL
,	NULL
but	NULL
freshly	NULL
isolated	NULL
alveolar	NULL
macrophages	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
produce	NULL
little	NULL
or	NULL
no	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
even	NULL
though	NULL
alveolar	NULL
macrophages	NULL
from	NULL
patients	NULL
with	NULL
granulomatous	NULL
diseases	NULL
do	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
when	NULL
cultured	NULL
in	NULL
vitro	NULL
for	NULL
4-7	NULL
d	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
such	NULL
as	NULL
T	NULL
lymphocytes	NULL
,	NULL
can	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
not	NULL
been	NULL
yet	NULL
evaluated	NULL
.	NULL

To	NULL
study	NULL
these	NULL
questions	NULL
,	NULL
we	NULL
have	NULL
evaluated	NULL
the	NULL
metabolism	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
by	NULL
fresh	NULL
cells	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
from	NULL
controls	NULL
and	NULL
normocalcemic	NULL
patients	NULL
with	NULL
tuberculosis	NULL
and	NULL
sarcoidosis	NULL
.	NULL

The	NULL
goals	NULL
of	NULL
this	NULL
study	NULL
were	NULL
to	NULL
compare	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
in	NULL
different	NULL
types	NULL
of	NULL
granulomatous	NULL
disease	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
cell	NULL
types	NULL
responsible	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
.	NULL

Methods	NULL
Study	NULL
populations	NULL
Patients	NULL
with	NULL
pulmonary	NULL
tuberculosis	NULL
.	NULL

The	NULL
diagnosis	NULL
of	NULL
pulmonary	NULL
tuberculosis	NULL
was	NULL
established	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
cultures	NULL
of	NULL
sputum	NULL
or	NULL
gastric	NULL
aspirates	NULL
positive	NULL
for	NULL
Mycobacterium	NULL
tuberculosis	NULL
(	NULL
n	NULL
=	NULL
11	NULL
)	NULL
and/or	NULL
the	NULL
presence	NULL
of	NULL
epithelioid	NULL
granulomata	NULL
with	NULL
caseous	NULL
necrosis	NULL
on	NULL
histological	NULL
study	NULL
of	NULL
biopsy	NULL
specimens	NULL
(	NULL
r	NULL
=	NULL
4	NULL
)	NULL
.	NULL

The	NULL
12	NULL
patients	NULL
had	NULL
a	NULL
mean	NULL
age	NULL
of	NULL
34+7	NULL
yr.	NULL
All	NULL
patients	NULL
had	NULL
a	NULL
normal	NULL
level	NULL
of	NULL
serum	NULL
calcium	NULL
(	NULL
2.34+0.10	NULL
mmol/liter	NULL
)	NULL
and	NULL
normal	NULL
24-h	NULL
urinary	NULL
calcium	NULL
excretion	NULL
(	NULL
0.04+0.03	NULL
mmol/kg	NULL
per	NULL
d	NULL
;	NULL
normal	NULL
range	NULL
<	NULL
0.11	NULL
mmol/kg	NULL
per	NULL
d	NULL
)	NULL
at	NULL
the	NULL
time	NULL
of	NULL
evaluation	NULL
.	NULL

Patients	NULL
were	NULL
studied	NULL
before	NULL
receiving	NULL
any	NULL
antituberculous	NULL
therapy	NULL
.	NULL

Patients	NULL
with	NULL
pulmonary	NULL
sarcoidosis	NULL
.	NULL

The	NULL
diagnosis	NULL
of	NULL
pulmonary	NULL
sarcoidosis	NULL
was	NULL
established	NULL
according	NULL
to	NULL
previously	NULL
described	NULL
criteria	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
six	NULL
patients	NULL
had	NULL
a	NULL
mean	NULL
age	NULL
of	NULL
37+10	NULL
yr	NULL
.	NULL

Chest	NULL
radiographic	NULL
types	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
type	NULL
I	NULL
(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
,	NULL
type	NULL
II	NULL
(	NULL
r	NULL
=	NULL
2	NULL
)	NULL
,	NULL
and	NULL
type	NULL
III	NULL
(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
.	NULL

The	NULL
patients	NULL
had	NULL
normal	NULL
serum	NULL
calcium	NULL
levels	NULL
(	NULL
2.37+0.15	NULL
mmol/liter	NULL
)	NULL
and	NULL
normal	NULL
urinary	NULL
calcium	NULL
excretion	NULL
(	NULL
0.08+0.03	NULL
mmol/kg	NULL
per	NULL
d	NULL
)	NULL
at	NULL
the	NULL
time	NULL
of	NULL
evaluation	NULL
.	NULL

One	NULL
patient	NULL
had	NULL
previously	NULL
received	NULL
corticoste-roid	NULL
therapy	NULL
,	NULL
which	NULL
had	NULL
been	NULL
discontinued	NULL
>	NULL
3	NULL
mo	NULL
before	NULL
evaluation	NULL
.	NULL

Control	NULL
subjects	NULL
.	NULL

Three	NULL
normal	NULL
volunteers	NULL
and	NULL
two	NULL
patients	NULL
undergoing	NULL
bronchoscopic	NULL
evaluation	NULL
for	NULL
nonparenchymal	NULL
pulmonary	NULL
disorders	NULL
served	NULL
as	NULL
controls	NULL
.	NULL

These	NULL
individuals	NULL
had	NULL
an	NULL
average	NULL
age	NULL
of	NULL
28+8	NULL
yr.	NULL
Bronchoalveolar	NULL
lavage	NULL
Informed	NULL
consent	NULL
was	NULL
obtained	NULL
from	NULL
all	NULL
patients	NULL
and	NULL
control	NULL
subjects	NULL
.	NULL

Bronchoalveolar	NULL
lavage	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
all	NULL
patients	NULL
,	NULL
a	NULL
radiologically	NULL
abnormal	NULL
lung	NULL
segment	NULL
was	NULL
lavaged	NULL
when	NULL
present	NULL
,	NULL
and	NULL
the	NULL
right	NULL
middle	NULL
lobe	NULL
or	NULL
lingula	NULL
lavaged	NULL
when	NULL
the	NULL
radio-graph	NULL
was	NULL
normal	NULL
.	NULL

Total	NULL
and	NULL
differential	NULL
cell	NULL
counts	NULL
and	NULL
the	NULL
evaluation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
surface	NULL
antigens	NULL
on	NULL
T	NULL
lymphocytes	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Separation	NULL
of	NULL
cell	NULL
populations	NULL
Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
centrifuga-tion	NULL
on	NULL
Lympho-paque	NULL
(	NULL
Nyegaard	NULL
Co.	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
medium	NULL
with	NULL
0.08	NULL
%	NULL
EDTA	NULL
and	NULL
centrifuged	NULL
(	NULL
100	NULL
g	NULL
for	NULL
15	NULL
min	NULL
)	NULL
two	NULL
times	NULL
to	NULL
remove	NULL
plate-lets	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
concentrated	NULL
fresh	NULL
lavage	NULL
cells	NULL
by	NULL
passage	NULL
through	NULL
nylon	NULL
wool	NULL
columns	NULL
using	NULL
previously	NULL
described	NULL
techniques	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
isolate	NULL
alveolar	NULL
macrophages	NULL
,	NULL
concentrated	NULL
lavage	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
complete	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
and	NULL
transferred	NULL
to	NULL
bacteriologic	NULL
petri	NULL
dishes	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
incubated	NULL
with	NULL
human	NULL
AB	NULL
serum	NULL
for	NULL
18	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
subsequently	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
phosphate	NULL
buffered	NULL
saline	NULL
(	NULL
12	NULL
)	NULL
.	NULL

After	NULL
a	NULL
60-min	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
complete	NULL
medium	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
10	NULL
ml	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
containing	NULL
0.2	NULL
%	NULL
EDTA	NULL
.	NULL

Cells	NULL
which	NULL
detached	NULL
spontaneously	NULL
or	NULL
after	NULL
gentle	NULL
pipet-ting	NULL
were	NULL
recovered	NULL
and	NULL
washed	NULL
in	NULL
complete	NULL
medium	NULL
before	NULL
use	NULL
.	NULL

The	NULL
viability	NULL
of	NULL
fresh	NULL
cells	NULL
recovered	NULL
by	NULL
lavage	NULL
stained	NULL
with	NULL
acridine	NULL
orange	NULL
and	NULL
ethidium	NULL
bromide	NULL
(	NULL
13	NULL
)	NULL
was	NULL
:	NULL
controls	NULL
,	NULL
86+2	NULL
%	NULL
(	NULL
mean+SD	NULL
)	NULL
;	NULL
tuberculosis	NULL
,	NULL
81+14	NULL
%	NULL
;	NULL
and	NULL
sarcoidosis	NULL
,	NULL
90+6	NULL
%	NULL
.	NULL

The	NULL
viability	NULL
and	NULL
purity	NULL
of	NULL
lavage	NULL
T	NULL
lymphocytes	NULL
were	NULL
respectively	NULL
:	NULL
controls	NULL
,	NULL
99+1	NULL
%	NULL
and	NULL
93+5	NULL
%	NULL
;	NULL
tuberculosis	NULL
,	NULL
96+5	NULL
%	NULL
and	NULL
96+3	NULL
%	NULL
;	NULL
and	NULL
sarcoidosis	NULL
,	NULL
98+1	NULL
%	NULL
and	NULL
95+5	NULL
%	NULL
.	NULL

The	NULL
viability	NULL
and	NULL
purity	NULL
of	NULL
pulmonary	NULL
macrophages	NULL
from	NULL
tuberculosis	NULL
patients	NULL
after	NULL
separation	NULL
by	NULL
adherence	NULL
were	NULL
respectively	NULL
98+1	NULL
%	NULL
and	NULL
97+4	NULL
%	NULL
.	NULL

Metabolism	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
by	NULL
cells	NULL
in	NULL
vitro	NULL
To	NULL
evaluate	NULL
the	NULL
capacity	NULL
of	NULL
cells	NULL
to	NULL
metabolize	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
vitro	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
viable	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
15	NULL
min	NULL
(	NULL
37°C	NULL
,	NULL
95	NULL
%	NULL
air/5	NULL
%	NULL
CO	NULL
;	NULL
)	NULL
in	NULL
a	NULL
2-cm	NULL
diameter	NULL
glass	NULL
vial	NULL
containing	NULL
1	NULL
ml	NULL
of	NULL
serum	NULL
free	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
1.8	NULL
mM	NULL
Ca®*	NULL
and	NULL
0.9	NULL
mM	NULL
phosphate	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
GmbH	NULL
,	NULL
Penzberg	NULL
,	NULL
FRG	NULL
)	NULL
.	NULL

10	NULL
l	NULL
of	NULL
ethanol	NULL
was	NULL
then	NULL
added	NULL
which	NULL
contained	NULL
either	NULL
:	NULL
(	NULL
a	NULL
)	NULL
50	NULL
nCi	NULL
{	NULL
26,27°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
(	NULL
Radiochemical	NULL
Centre	NULL
,	NULL
Amersham	NULL
,	NULL
UK	NULL
;	NULL
final	NULL
concentration	NULL
2.5	NULL
X	NULL
107°	NULL
M	NULL
and	NULL
final	NULL
20	NULL
Ci/mmol	NULL
sp	NULL
act	NULL
)	NULL
;	NULL
or	NULL
(	NULL
b	NULL
)	NULL
1	NULL
ug	NULL
unlabeled	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
(	NULL
Roussel-Uclaf	NULL
Laboratories	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
with	NULL
or	NULL
without	NULL
50	NULL
nCi	NULL
[	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
(	NULL
final	NULL
concentration	NULL
1	NULL
X	NULL
10~°	NULL
M	NULL
and	NULL
final	NULL
specific	NULL
activity	NULL
20	NULL
mCi/mmo	NULL
!	NULL
)	NULL

.	NULL

Incubation	NULL
was	NULL
continued	NULL
for	NULL
150	NULL
min	NULL
,	NULL
after	NULL
which	NULL
2	NULL
ml	NULL
HPLC	NULL
grade	NULL
methanol	NULL
and	NULL
2	NULL
ml	NULL
chloroform	NULL
were	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
,	NULL
the	NULL
vials	NULL
agitated	NULL
,	NULL
the	NULL
chloroform	NULL
phase	NULL
removed	NULL
and	NULL
dried	NULL
under	NULL
N	NULL
;	NULL
,	NULL
and	NULL
the	NULL
residue	NULL
redissolved	NULL
in	NULL
chromatographic	NULL
solvent	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Before	NULL
chromatography	NULL
,	NULL
100	NULL
ng	NULL
unlabeled	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Hoffmman-La	NULL
Roche	NULL
,	NULL
Inc.	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
was	NULL
added	NULL
to	NULL
extracts	NULL
from	NULL
cells	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
X	NULL
10~°	NULL
M	NULL
[	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
and	NULL
10	NULL
nCi	NULL
synthetic	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
added	NULL
to	NULL
those	NULL
incubated	NULL
with	NULL
1	NULL
x	NULL
10~°	NULL
M	NULL
unlabeled	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
.	NULL

To	NULL
quantify	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
,	NULL
samples	NULL
were	NULL
chromatographed	NULL
using	NULL
a	NULL
»	NULL
-hexane	NULL
:	NULL
isopropanol	NULL
solvent	NULL
system	NULL
,	NULL
and	NULL
the	NULL
metabolites	NULL
comigrating	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
were	NULL
rechromatographed	NULL
using	NULL
a	NULL
methylene-chloride	NULL
:	NULL
isopropanol	NULL
solvent	NULL
system	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Chromatography	NULL
of	NULL
samples	NULL
on	NULL
two	NULL
successive	NULL
systems	NULL
was	NULL
obligatory	NULL
to	NULL
isolate	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
since	NULL
large	NULL
amounts	NULL
of	NULL
(	NULL
5E	NULL
)	NULL
-19-nor-10-ox0-25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
were	NULL
produced	NULL
by	NULL
the	NULL
cells	NULL
and	NULL
comigrated	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
first	NULL
,	NULL
but	NULL
not	NULL
the	NULL
second	NULL
chromatographic	NULL
system	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
incubations	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
X	NULL
10~°	NULL
M	NULL
PH	NULL
]	NULL
-25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
conversion	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
[	NULL
°H	NULL
]	NULL
-1,25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
was	NULL
determined	NULL
by	NULL
calculating	NULL
the	NULL
percentage	NULL
of	NULL
total	NULL
radioactivity	NULL
with	NULL
an	NULL
appropriate	NULL
elution	NULL
profile	NULL
after	NULL
the	NULL
two	NULL
successive	NULL
chromatographies	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
fmol/10°	NULL
cells	NULL
per	NULL
150	NULL
min	NULL
,	NULL
based	NULL
on	NULL
the	NULL
assumption	NULL
that	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
product	NULL
was	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
the	NULL
substrate	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
conversion	NULL
of	NULL
1	NULL
%	NULL
of	NULL
substrate	NULL
into	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
corresponds	NULL
to	NULL
the	NULL
production	NULL
of	NULL
33	NULL
fmol	NULL
.	NULL

All	NULL
incubations	NULL
and	NULL
the	NULL
subsequent	NULL
purification	NULL
of	NULL
metabolite	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
each	NULL
value	NULL
reported	NULL
in	NULL
the	NULL
study	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
duplicate	NULL
determinations	NULL
.	NULL

The	NULL
interassay	NULL
coefficient	NULL
of	NULL
variation	NULL
of	NULL
the	NULL
duplicate	NULL
determinations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
25+4	NULL
%	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
lavage	NULL
cells	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
linear	NULL
over	NULL
the	NULL
150-min	NULL
period	NULL
studied	NULL
.	NULL

Furthermore	NULL
,	NULL
<	NULL
15	NULL
%	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
added	NULL
to	NULL
lavage	NULL
cell	NULL
incubations	NULL
was	NULL
consumed	NULL
over	NULL
the	NULL
incubation	NULL
period	NULL
.	NULL

When	NULL
medium	NULL
without	NULL
cells	NULL
(	NULL
rn	NULL
=	NULL
4	NULL
)	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
X	NULL
10~°	NULL
M	NULL
[	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
0-0.065	NULL
%	NULL
isotope	NULL
eluted	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

This	NULL
background	NULL
value	NULL
has	NULL
not	NULL
been	NULL
subtracted	NULL
from	NULL
the	NULL
values	NULL
reported	NULL
for	NULL
incubations	NULL
containing	NULL
cells	NULL
.	NULL

|	NULL
To	NULL
measure	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
in	NULL
incubations	NULL
containing	NULL
1	NULL
X	NULL
10~°	NULL
M	NULL
PH	NULL
]	NULL
J25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
purified	NULL
as	NULL
described	NULL
above	NULL
by	NULL
sequential	NULL
chromatography	NULL
using	NULL
the	NULL
two	NULL
different	NULL
solvent	NULL
systems	NULL
and	NULL
the	NULL
absorbance	NULL
at	NULL
254	NULL
nm	NULL
and	NULL
radioactivity	NULL
of	NULL
the	NULL
isolated	NULL
metabolite	NULL
were	NULL
determined	NULL
.	NULL

Ultraviolet	NULL
(	NULL
UV	NULL
)	NULL
absorption	NULL
spectra	NULL
of	NULL
the	NULL
purified	NULL
metabolite	NULL
were	NULL
obtained	NULL
using	NULL
a	NULL
HPLC	NULL
system	NULL
fitted	NULL
with	NULL
a	NULL
photodiode	NULL
array	NULL
detector	NULL
(	NULL
model	NULL
990	NULL
;	NULL
Millipore/Continental	NULL
Water	NULL
Systems	NULL
,	NULL
St.	NULL
Quentin	NULL
en	NULL
Welinnes	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
metabolites	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptors	NULL
To	NULL
characterize	NULL
the	NULL
ability	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
metabolites	NULL
to	NULL
bind	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptors	NULL
,	NULL
metabolites	NULL
produced	NULL
in	NULL
incubations	NULL
containing	NULL
1	NULL
X	NULL
107°	NULL
M	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
were	NULL
purified	NULL
by	NULL
successive	NULL
chromatogra-phies	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
synthetic	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
binding	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptors	NULL
present	NULL
in	NULL
chick	NULL
intestinal	NULL
cytosol	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
samples	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PH	NULL
]	NULL
J25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
measurement	NULL
of	NULL
the	NULL
quantity	NULL
of	NULL
metabolite	NULL
present	NULL
was	NULL
based	NULL
on	NULL
radioactivity	NULL
,	NULL
assuming	NULL
that	NULL
the	NULL
specific	NULL
activity	NULL
was	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
the	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
substrate	NULL
.	NULL

For	NULL
samples	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
measurement	NULL
of	NULL
the	NULL
quantity	NULL
of	NULL
metabolite	NULL
present	NULL
was	NULL
based	NULL
on	NULL
its	NULL
absorbance	NULL
at	NULL
254	NULL
nm	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
tested	NULL
in	NULL
duplicate	NULL
at	NULL
three	NULL
different	NULL
dilutions	NULL
.	NULL

A	NULL
standard	NULL
curve	NULL
was	NULL
performed	NULL
in	NULL
parallel	NULL
using	NULL
known	NULL
amounts	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
displacement	NULL
of	NULL
binding	NULL
produced	NULL
by	NULL
the	NULL
standards	NULL
and	NULL
experimental	NULL
samples	NULL
were	NULL
each	NULL
fitted	NULL
to	NULL
sigmoid	NULL
curves	NULL
and	NULL
compared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
using	NULL
the	NULL
Ligand	NULL
program	NULL
provided	NULL
by	NULL
these	NULL
authors	NULL
.	NULL

Statistical	NULL
methods	NULL
Results	NULL
are	NULL
expressed	NULL
as	NULL
mean+SD	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
production	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
metabolites	NULL
by	NULL
the	NULL
three	NULL
study	NULL
groups	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
Kruskal-Wallis	NULL
one-way	NULL
analysis	NULL
of	NULL
ranks	NULL
procedure	NULL
,	NULL
and	NULL
comparisons	NULL
between	NULL
subgroups	NULL
of	NULL
patients	NULL
within	NULL
a	NULL
given	NULL
diagnostic	NULL
category	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Mann-Whitney	NULL
test	NULL
.	NULL

Correlations	NULL
between	NULL
the	NULL
production	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
,	NULL
metabolites	NULL
and	NULL
other	NULL
metric	NULL
variables	NULL
were	NULL
evaluated	NULL
by	NULL
linear	NULL
regression	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
a	NULL
P	NULL
<	NULL
0.05	NULL
was	NULL
considered	NULL
significant	NULL
.	NULL

Results	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
lavage	NULL
cells	NULL
and	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Fresh	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
X	NULL
10~	NULL
M	NULL
[	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
produced	NULL
a	NULL
metabolite	NULL
which	NULL
coeluted	NULL
with	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
two	NULL
successive	NULL
chromatographic	NULL
systems	NULL
.	NULL

Further	NULL
studies	NULL
supported	NULL
the	NULL
conclusion	NULL
that	NULL
this	NULL
metabolite	NULL
was	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

When	NULL
lavage	NULL
cells	NULL
from	NULL
these	NULL
patients	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10~°	NULL
M	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
and	NULL
extracts	NULL
chromatographed	NULL
successively	NULL
on	NULL
the	NULL
two	NULL
HPLC	NULL
systems	NULL
,	NULL
a	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
Production	NULL
by	NULL
Lung	NULL
T	NULL
Lymphocytes	NULL
-	NULL
1589	NULL
metabolite	NULL
coeluting	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
by	NULL
monitoring	NULL
absorbance	NULL
,	NULL
and	NULL
this	NULL
metabolite	NULL
had	NULL
the	NULL
same	NULL
capacity	NULL
as	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
to	NULL
compete	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
binding	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptors	NULL
and	NULL
its	NULL
UV	NULL
spectrum	NULL
had	NULL
a	NULL
maximum	NULL
at	NULL
267	NULL
nm	NULL
and	NULL
a	NULL
minimum	NULL
at	NULL
228	NULL
nm	NULL
,	NULL
values	NULL
identical	NULL
to	NULL
those	NULL
observed	NULL
for	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fresh	NULL
lavage	NULL
cells	NULL
from	NULL
tuberculosis	NULL
patients	NULL
produced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
all	NULL
cases	NULL
,	NULL
although	NULL
the	NULL
amounts	NULL
of	NULL
total	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
converted	NULL
into	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
varied	NULL
over	NULL
a	NULL
10-fold	NULL
range	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
three	NULL
of	NULL
the	NULL
five	NULL
patients	NULL
with	NULL
tuberculosis	NULL
tested	NULL
also	NULL
produced	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
but	NULL
the	NULL
production	NULL
of	NULL
this	NULL
metabolite	NULL
by	NULL
blood	NULL
mononuclear	NULL
cells	NULL
was	NULL
always	NULL
less	NULL
than	NULL
that	NULL
produced	NULL
by	NULL
the	NULL
same	NULL
number	NULL
of	NULL
lavage	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
by	NULL
paired	NULL
analysis	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
fresh	NULL
lavage	NULL
cells	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
proportion	NULL
of	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
present	NULL
in	NULL
the	NULL
cell	NULL
suspension	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
r	NULL
=	NULL
0.67	NULL
,	NULL
P	NULL
<	NULL
0.005	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
proportion	NULL
of	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
,	NULL
total	NULL
lymphocytes	NULL
or	NULL
alveolar	NULL
macrophages	NULL
present	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
[	NULL
°H	NULL
}	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
was	NULL
observed	NULL
in	NULL
two	NULL
of	NULL
six	NULL
cases	NULL
,	NULL
but	NULL
only	NULL
small	NULL
amounts	NULL
were	NULL
present	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
was	NULL
significantly	NULL
less	NULL
than	NULL
that	NULL
of	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

No	NULL
conversion	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
J25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
detected	NULL
by	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
the	NULL
three	NULL
sarcoid	NULL
patients	NULL
tested	NULL
.	NULL

Simi-larly	NULL
,	NULL
lavage	NULL
cells	NULL
and	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
controls	NULL
did	NULL
not	NULL
produce	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Identification	NULL
of	NULL
cell	NULL
types	NULL
recovered	NULL
by	NULL
lavage	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
capable	NULL
of	NULL
converting	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Lymphocytes	NULL
and	NULL
alveolar	NULL
macrophages	NULL
were	NULL
the	NULL
predominant	NULL
cell	NULL
types	NULL
recovered	NULL
by	NULL
lavage	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
,	NULL
and	NULL
in	NULL
7/12	NULL
individuals	NULL
,	NULL
these	NULL
two	NULL
cell	NULL
types	NULL
accounted	NULL
for	NULL
>	NULL
80	NULL
%	NULL
of	NULL
recovered	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
of	NULL
these	NULL
cell	NULL
types	NULL
could	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
the	NULL
two	NULL
populations	NULL
were	NULL
separated	NULL
and	NULL
studied	NULL
individually	NULL
.	NULL

Lymphocytes	NULL
.	NULL

Lavage	NULL
T	NULL
lymphocytes	NULL
from	NULL
all	NULL
eight	NULL
patients	NULL
with	NULL
tuberculosis	NULL
tested	NULL
were	NULL
able	NULL
to	NULL
convert	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
lavage	NULL
T	NULL
Table	NULL
I	NULL
.	NULL

Production	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
Blood	NULL
Mononuclear	NULL
Cells	NULL
and	NULL
Lavage	NULL
Cells	NULL
from	NULL
Control	NULL
Subjects	NULL
and	NULL
Patients	NULL
with	NULL
Tuberculosis	NULL
and	NULL
Sarcoidosis*	NULL
production	NULL
Cell	NULL
type	NULL
Controls	NULL
Tuberculosis	NULL
Sarcoidosis	NULL
Fmol/10®	NULL
cells	NULL
per	NULL
150	NULL
min	NULL
Blood	NULL
mononuclear	NULL
cells	NULL
<	NULL
0.2	NULL
<	NULL
l.1	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
(	NULL
n	NULL
=	NULL
5	NULL
)	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
Unseparated	NULL
lavage	NULL
cells	NULL
<	NULL
0.2	NULL
10.1+8.7	NULL
``	NULL
21+1.2	NULL
(	NULL
n	NULL
=	NULL
5	NULL
)	NULL
(	NULL
n	NULL
=	NULL
12	NULL
)	NULL
(	NULL
n	NULL
=	NULL
6	NULL
)	NULL
*	NULL
Results	NULL
are	NULL
given	NULL
as	NULL
mean+SD	NULL
.	NULL

t	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
comparing	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
lavage	NULL
cells	NULL
;	NULL
$	NULL
,	NULL
P	NULL
<	NULL
0.01	NULL
or	NULL
``	NULL
,	NULL
P	NULL
<	NULL
0.001	NULL
comparing	NULL
tuberculosis	NULL
patients	NULL
with	NULL
control	NULL
subjects	NULL
and	NULL
sarcoidosis	NULL
patients	NULL
.	NULL

1590	NULL
_-	NULL
Cadranel	NULL
,	NULL
Garabedian	NULL
,	NULL
Milleron	NULL
,	NULL
Guillozo	NULL
,	NULL
Akoun	NULL
,	NULL
and	NULL
Hance	NULL
40	NULL
|	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
D3PRODUCED	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
CD	NULL
8*	NULL
LYMPHOCYTES	NULL
PRESENT	NULL
(	NULL
x	NULL
104	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Correlation	NULL
between	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
and	NULL
the	NULL
number	NULL
of	NULL
CD8*	NULL
lymphocytes	NULL
present	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
was	NULL
determined	NULL
by	NULL
linear	NULL
regression	NULL
(	NULL
r	NULL
=	NULL
0.67	NULL
,	NULL
P	NULL
<	NULL
0.005	NULL
)	NULL
.	NULL

lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
or	NULL
normals	NULL
did	NULL
not	NULL
produce	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Additional	NULL
experiments	NULL
confirmed	NULL
the	NULL
identification	NULL
of	NULL
this	NULL
metabolite	NULL
as	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

First	NULL
,	NULL
purified	NULL
T	NULL
lymphocytes	NULL
from	NULL
the	NULL
five	NULL
tuberculosis	NULL
patients	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
1	NULL
xX	NULL
10~°	NULL
M	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
produced	NULL
a	NULL
metabolite	NULL
detected	NULL
by	NULL
UV	NULL
absorbance	NULL
at	NULL
254	NULL
nm	NULL
which	NULL
coeluted	NULL
with	NULL
synthetic	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
two	NULL
sequential	NULL
HPLC	NULL
chromatographic	NULL
systems	NULL
.	NULL

Second	NULL
,	NULL
when	NULL
T	NULL
lymphocytes	NULL
from	NULL
patients	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
X	NULL
10~°	NULL
M	NULL
[	NULL
PH	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
(	NULL
20+2	NULL
mCi/mmol	NULL
sp	NULL
act	NULL
)	NULL
,	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
metabolite	NULL
was	NULL
similar	NULL
(	NULL
19+2	NULL
mCi/mmol	NULL
sp	NULL
act	NULL
;	NULL
n	NULL
=	NULL
5	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
when	NULL
the	NULL
metabolite	NULL
isolated	NULL
from	NULL
nine	NULL
individual	NULL
patients	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
receptor-binding	NULL
assay	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
its	NULL
receptor	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
when	NULL
the	NULL
metabolite	NULL
with	NULL
chromatographic	NULL
properties	NULL
of	NULL
ra	NULL
o	NULL
j	NULL
1	NULL
Figure	NULL
2	NULL
.	NULL

Production	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
by	NULL
lavage	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
purified	NULL
from	NULL
cells	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
from	NULL
normals	NULL
(	NULL
C	NULL
)	NULL
,	NULL
patients	NULL
with	NULL
tuber-e	NULL
culosis	NULL
(	NULL
T	NULL
)	NULL
,	NULL
and	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
1,25	NULL
(	NULL
OHpDsPRODUCED	NULL
(	NULL
FMOLA1O®T	NULL
LYMPHOCYTES	NULL
)	NULL
a	NULL
+	NULL
a	NULL
oo	NULL
(	NULL
S	NULL
)	NULL
.	NULL

1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
e	NULL
|	NULL
incubated	NULL
in	NULL
the	NULL
gras-o	NULL
§\\\§\\\	NULL
;	NULL
\\\	NULL
%	NULL
\\\§\\§	NULL
Fﬁzziéég	NULL
:	NULL
,0	NULL
anxhe	NULL
T	NULL
s	NULL
c	NULL
amount	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
shaded	NULL
areas	NULL
represent	NULL
the	NULL
apparent	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
incubations	NULL
performed	NULL
without	NULL
added	NULL
cells	NULL
.	NULL

100	NULL
20	NULL
,	NULL
PERCENT	NULL
MAXIMAL	NULL
BINDING	NULL
&	NULL
n	NULL
o	NULL
ABSORBANCE	NULL
X	NULL
10°	NULL
0	NULL
4	NULL
+	NULL
R	NULL
0	NULL
Figure	NULL
3	NULL
.	NULL

Characterization	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
by	NULL
T	NULL
lymphocytes	NULL
.	NULL

Lavage	NULL
T	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
M	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
and	NULL
the	NULL
metabolite	NULL
comigrating	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
two	NULL
consecutive	NULL
chromatographic	NULL
systems	NULL
was	NULL
isolated	NULL
.	NULL

The	NULL
concentration	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

(	NULL
Leff	NULL
)	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
1,25	NULL
(	NULL
OHMpDs	NULL
ADDED	NULL
(	NULL
pg	NULL
)	NULL
aso	NULL
=	NULL
300	NULL
350	NULL
Ability	NULL
of	NULL
this	NULL
metabolite	NULL
to	NULL
displace	NULL
the	NULL
binding	NULL
of	NULL
PH	NULL
]	NULL
-	NULL
WAVELENGTH	NULL
(	NULL
nm	NULL
)	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
its	NULL
receptor	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
known	NULL
amounts	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

Each	NULL
symbol	NULL
type	NULL
represents	NULL
data	NULL
from	NULL
a	NULL
single	NULL
individual	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
The	NULL
absorption	NULL
spectra	NULL
of	NULL
this	NULL
metabolite	NULL
(	NULL
Reavy	NULL
solid	NULL
line	NULL
)	NULL
and	NULL
that	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
light	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
isolated	NULL
from	NULL
five	NULL
different	NULL
patients	NULL
,	NULL
pooled	NULL
,	NULL
and	NULL
rechromatographed	NULL
using	NULL
the	NULL
methylene-chloride	NULL
:	NULL
isopropanol	NULL
solvent	NULL
system	NULL
,	NULL
this	NULL
metabolite	NULL
eluted	NULL
as	NULL
a	NULL
sharp	NULL
single	NULL
peak	NULL
with	NULL
an	NULL
elution	NULL
volume	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
had	NULL
the	NULL
same	NULL
capacity	NULL
as	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
compete	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
binding	NULL
to	NULL
receptors	NULL
present	NULL
in	NULL
chick	NULL
intestinal	NULL
cytosol	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
UV	NULL
spectrum	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
only	NULL
known	NULL
vitamin	NULL
D	NULL
metabolite	NULL
with	NULL
these	NULL
characteristics	NULL
is	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
evidence	NULL
indicated	NULL
that	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
did	NULL
not	NULL
result	NULL
from	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
by	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
alveolar	NULL
macrophages	NULL
)	NULL
contaminating	NULL
the	NULL
lymphocyte	NULL
preparations	NULL
.	NULL

First	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
T	NULL
lymphocytes	NULL
correlated	NULL
with	NULL
the	NULL
number	NULL
of	NULL
CD8*	NULL
lymphocytes	NULL
,	NULL
not	NULL
the	NULL
number	NULL
of	NULL
alveolar	NULL
macrophages	NULL
,	NULL
present	NULL
in	NULL
the	NULL
original	NULL
cell	NULL
population	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
production	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
purified	NULL
T	NULL
lymphocytes	NULL
correlated	NULL
very	NULL
closely	NULL
with	NULL
the	NULL
production	NULL
of	NULL
[	NULL
}	NULL
H	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
unseparated	NULL
fresh	NULL
lavage	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
r	NULL
20	NULL
a	NULL
w	NULL
E	NULL
e	NULL
8	NULL
&	NULL
-	NULL
e	NULL
€	NULL
>	NULL
€	NULL
3	NULL
E10-	NULL
o	NULL
fs	NULL
)	NULL
e	NULL
[	NULL
=	NULL
]	NULL
6	NULL
E	NULL
-	NULL
_	NULL
e	NULL
bat	NULL
$	NULL
Fa	NULL
o	NULL
~	NULL
1	NULL
1	NULL
1	NULL
)	NULL
0	NULL
20	NULL
40	NULL
1,25	NULL
(	NULL
OHpD3PRODUCED	NULL
Figure	NULL
4	NULL
.	NULL

Correlation	NULL
between	NULL
the	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
fresh	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
and	NULL
purified	NULL
lavage	NULL
T	NULL
lymphocytes	NULL
from	NULL
the	NULL
same	NULL
individuals	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
was	NULL
determined	NULL
by	NULL
linear	NULL
regression	NULL
(	NULL
r	NULL
=	NULL
0.95	NULL
,	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

=	NULL
0.95	NULL
,	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
T	NULL
lymphocytes	NULL
used	NULL
for	NULL
these	NULL
experiments	NULL
had	NULL
a	NULL
purity	NULL
of	NULL
>	NULL
95	NULL
%	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
incubations	NULL
could	NULL
have	NULL
contained	NULL
at	NULL
most	NULL
5	NULL
X	NULL
10°	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
whereas	NULL
incubations	NULL
containing	NULL
10°	NULL
alveolar	NULL
macrophages	NULL
or	NULL
fresh	NULL
lavage	NULL
cells	NULL
did	NULL
not	NULL
produce	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fourth	NULL
,	NULL
alveolar	NULL
macrophages	NULL
from	NULL
one	NULL
tuberculosis	NULL
patient	NULL
did	NULL
not	NULL
produce	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
although	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
unseparated	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Alveolar	NULL
macrophages	NULL
.	NULL

When	NULL
purified	NULL
alveolar	NULL
macrophages	NULL
(	NULL
purity	NULL
97+4	NULL
%	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
(	NULL
all	NULL
of	NULL
whose	NULL
unseparated	NULL
lavage	NULL
cells	NULL
produced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.5	NULL
X	NULL
10~°	NULL
M	NULL
[	NULL
PHJ	NULL
}	NULL
25	NULL
(	NULL
OHM	NULL
)	NULL
D	NULL
;	NULL
production	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
detectable	NULL
in	NULL
two	NULL
cases	NULL
,	NULL
but	NULL
not	NULL
with	NULL
cells	NULL
from	NULL
the	NULL
third	NULL
individual	NULL
tested	NULL
(	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
production	NULL
;	NULL
9.3	NULL
,	NULL
4.0	NULL
,	NULL
and	NULL
0	NULL
fmol/10°	NULL
cells	NULL
per	NULL
150	NULL
min	NULL
)	NULL
.	NULL

The	NULL
metabolite	NULL
produced	NULL
by	NULL
alveolar	NULL
macrophages	NULL
from	NULL
the	NULL
two	NULL
individuals	NULL
that	NULL
coeluted	NULL
with	NULL
synthetic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
confirmed	NULL
to	NULL
have	NULL
the	NULL
properties	NULL
expected	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
the	NULL
spectroscopic	NULL
and	NULL
receptor-binding	NULL
methods	NULL
described	NULL
earlier	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
directly	NULL
related	NULL
to	NULL
the	NULL
number	NULL
of	NULL
alveolar	NULL
macrophages	NULL
included	NULL
in	NULL
the	NULL
incubation	NULL
between	NULL
10°	NULL
and	NULL
10°	NULL
cells/incubation	NULL
,	NULL
but	NULL
no	NULL
conversion	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
into	NULL
[	NULL
PH	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
incubations	NULL
containing	NULL
<	NULL
10°	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
The	NULL
spontaneous	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
fresh	NULL
ceils	NULL
or	NULL
tissue	NULL
obtained	NULL
from	NULL
sites	NULL
of	NULL
granulomatous	NULL
reactions	NULL
in	NULL
a	NULL
small	NULL
number	NULL
of	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
or	NULL
tuberculosis	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
,	NULL
all	NULL
of	NULL
whom	NULL
had	NULL
obvious	NULL
abnormalities	NULL
in	NULL
calcium	NULL
metabolism	NULL
(	NULL
3-5	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Our	NULL
study	NULL
extends	NULL
these	NULL
observations	NULL
in	NULL
several	NULL
ways	NULL
:	NULL
(	NULL
a	NULL
)	NULL
It	NULL
suggests	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
immune	NULL
and	NULL
inflammatory	NULL
cells	NULL
is	NULL
occurring	NULL
in	NULL
most	NULL
patients	NULL
with	NULL
tuberculosis	NULL
,	NULL
and	NULL
is	NULL
not	NULL
limited	NULL
to	NULL
the	NULL
small	NULL
proportion	NULL
of	NULL
patients	NULL
with	NULL
systemic	NULL
abnormalities	NULL
in	NULL
calcium	NULL
metabolism	NULL
(	NULL
5	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
It	NULL
suggests	NULL
that	NULL
the	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
is	NULL
regulated	NULL
differently	NULL
in	NULL
different	NULL
granulomatous	NULL
diseases	NULL
,	NULL
for	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
lavage	NULL
cells	NULL
was	NULL
detectable	NULL
in	NULL
all	NULL
12	NULL
patients	NULL
with	NULL
tuberculosis	NULL
tested	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Production	NULL
by	NULL
Lung	NULL
T	NULL
Lymphocytes	NULL
_	NULL
1591	NULL
whereas	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
production	NULL
was	NULL
detectable	NULL
in	NULL
only	NULL
two	NULL
of	NULL
the	NULL
six	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
and	NULL
for	NULL
both	NULL
individuals	NULL
only	NULL
small	NULL
amounts	NULL
were	NULL
produced	NULL
.	NULL

(	NULL
c	NULL
)	NULL
This	NULL
study	NULL
demonstrates	NULL
that	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
sites	NULL
of	NULL
granulomatous	NULL
lesions	NULL
,	NULL
because	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
some	NULL
patients	NULL
with	NULL
tuberculosis	NULL
were	NULL
capable	NULL
of	NULL
producing	NULL
detectable	NULL
amounts	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
also	NULL
define	NULL
the	NULL
cell	NULL
types	NULL
recovered	NULL
by	NULL
lavage	NULL
that	NULL
can	NULL
contribute	NULL
to	NULL
the	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Our	NULL
findings	NULL
indicate	NULL
that	NULL
T	NULL
lymphocytes	NULL
recovered	NULL
by	NULL
lavage	NULL
from	NULL
patients	NULL
with	NULL
tuberculosis	NULL
spontaneously	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

The	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
could	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
nonspecific	NULL
activation	NULL
of	NULL
the	NULL
lymphocytes	NULL
during	NULL
the	NULL
purification	NULL
procedure	NULL
,	NULL
for	NULL
none	NULL
of	NULL
the	NULL
lavage	NULL
T	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
and	NULL
normals	NULL
produced	NULL
detectable	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
evidence	NULL
indicated	NULL
that	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
did	NULL
not	NULL
result	NULL
from	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
produced	NULL
by	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
alveolar	NULL
macrophages	NULL
)	NULL
contaminating	NULL
the	NULL
lymphocyte	NULL
preparations	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
close	NULL
correlation	NULL
observed	NULL
between	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
fresh	NULL
lavage	NULL
cells	NULL
and	NULL
purified	NULL
lavage	NULL
T	NULL
lymphocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
suggests	NULL
that	NULL
T	NULL
lymphocytes	NULL
are	NULL
an	NULL
important	NULL
source	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
produced	NULL
by	NULL
lavage	NULL
cells	NULL
.	NULL

The	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
normal	NULL
T	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
detected	NULL
,	NULL
although	NULL
extrarenal	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
occur	NULL
in	NULL
patients	NULL
with	NULL
adult	NULL
T	NULL
cell	NULL
leukemia/lymphoma	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
HTLV1-transformed	NULL
cord	NULL
blood	NULL
T	NULL
lymphocytes	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
20	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
lavage	NULL
cells	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
number	NULL
of	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
present	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
number	NULL
of	NULL
CD4+*	NULL
T	NULL
lymphocytes	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
CD8+*	NULL
lymphocytes	NULL
are	NULL
the	NULL
major	NULL
source	NULL
of	NULL
this	NULL
metabolite	NULL
.	NULL

Other	NULL
explanations	NULL
are	NULL
possible	NULL
for	NULL
the	NULL
observed	NULL
correlation	NULL
however	NULL
,	NULL
such	NULL
as	NULL
the	NULL
possibility	NULL
that	NULL
CD8*	NULL
cells	NULL
produce	NULL
cyto-kines	NULL
which	NULL
stimulate	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
in	NULL
other	NULL
cells	NULL
,	NULL
or	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
favors	NULL
the	NULL
expansion	NULL
of	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Even	NULL
if	NULL
CD8+*	NULL
lymphocytes	NULL
are	NULL
directly	NULL
involved	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
,	NULL
they	NULL
must	NULL
be	NULL
activated	NULL
to	NULL
do	NULL
so	NULL
,	NULL
since	NULL
the	NULL
proportion	NULL
of	NULL
CD8*	NULL
T	NULL
lymphocytes	NULL
recovered	NULL
by	NULL
lavage	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
of	NULL
patients	NULL
with	NULL
tuberculosis	NULL
.	NULL

These	NULL
studies	NULL
also	NULL
demonstrate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
freshly	NULL
purified	NULL
alveolar	NULL
macrophages	NULL
from	NULL
some	NULL
tuberculosis	NULL
patients	NULL
can	NULL
spontaneously	NULL
produce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
unfractionated	NULL
lavage	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
(	NULL
containing	NULL
a	NULL
majority	NULL
of	NULL
alveolar	NULL
macrophages	NULL
in	NULL
each	NULL
case	NULL
)	NULL
produced	NULL
little	NULL
or	NULL
no	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
observation	NULL
that	NULL
fresh	NULL
alveolar	NULL
macrophages	NULL
from	NULL
sarcoidosis	NULL
patients	NULL
produce	NULL
little	NULL
or	NULL
no	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
the	NULL
cells	NULL
can	NULL
not	NULL
explain	NULL
these	NULL
re-sults	NULL
,	NULL
because	NULL
little	NULL
apparent	NULL
degradation	NULL
of	NULL
preformed	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
observed	NULL
over	NULL
the	NULL
period	NULL
of	NULL
incubation	NULL
.	NULL

Because	NULL
changes	NULL
in	NULL
``	NULL
maturation	NULL
``	NULL
or	NULL
``	NULL
differentiation	NULL
``	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
in	NULL
vitro	NULL
culture	NULL
increases	NULL
their	NULL
capacity	NULL
to	NULL
produce	NULL
this	NULL
metabolite	NULL
(	NULL
22	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
low	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
freshly	NULL
isolated	NULL
sarcoid	NULL
alveolar	NULL
macrophages	NULL
reflects	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
are	NULL
often	NULL
relatively	NULL
immature	NULL
(	NULL
23	NULL
)	NULL
,	NULL
or	NULL
reflects	NULL
a	NULL
basic	NULL
difference	NULL
in	NULL
the	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
tuberculosis	NULL
and	NULL
sarcoidosis	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
this	NULL
study	NULL
indicates	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
pro	NULL
1592	NULL
Cadranel	NULL
,	NULL
Garabedian	NULL
,	NULL
Milleron	NULL
,	NULL
Guillozo	NULL
,	NULL
Akoun	NULL
,	NULL
and	NULL
Hance	NULL
duction	NULL
occurs	NULL
commonly	NULL
in	NULL
tuberculosis	NULL
,	NULL
and	NULL
that	NULL
T	NULL
lymphocytes	NULL
,	NULL
possibly	NULL
CD8+*	NULL
T	NULL
lymphocytes	NULL
,	NULL
are	NULL
an	NULL
important	NULL
source	NULL
of	NULL
this	NULL
mediator	NULL
.	NULL

Because	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
can	NULL
improve	NULL
the	NULL
capacity	NULL
of	NULL
macrophages	NULL
to	NULL
kill	NULL
mycobacteria	NULL
(	NULL
24-26	NULL
)	NULL
,	NULL
our	NULL
results	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
macrophage-lymphocyte	NULL
in-teractions	NULL
,	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
may	NULL
be	NULL
an	NULL
important	NULL
component	NULL
of	NULL
a	NULL
successful	NULL
antituberculous	NULL
immune	NULL
response	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
gratefully	NULL
acknowledge	NULL
the	NULL
help	NULL
of	NULL
Alain	NULL
Loiseau	NULL
in	NULL
performing	NULL
the	NULL
statistical	NULL
analyses	NULL
,	NULL
Jacques	NULL
Hervagault	NULL
(	NULL
Millipore/Conti-nental	NULL
Water	NULL
Systems	NULL
)	NULL
in	NULL
performing	NULL
the	NULL
UV	NULL
spectroscopy	NULL
,	NULL
Francoise	NULL
Paillard	NULL
(	NULL
Hopital	NULL
Tenon	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
in	NULL
performing	NULL
some	NULL
of	NULL
the	NULL
clinical	NULL
analyses	NULL
,	NULL
and	NULL
Dominique	NULL
Valeyre	NULL
and	NULL
Jean-Paul	NULL
Battesti	NULL
(	NULL
Hopital	NULL
Avicenne	NULL
,	NULL
Bobigny	NULL
)	NULL
for	NULL
providing	NULL
lavage	NULL
samples	NULL
and	NULL
clinical	NULL
information	NULL
for	NULL
some	NULL
of	NULL
the	NULL
patients	NULL
studied	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Reichel	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Norman	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
endocrine	NULL
system	NULL
in	NULL
health	NULL
and	NULL
disease	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

320:980-991	NULL
.	NULL

2	NULL
.	NULL

Rigby	NULL
,	NULL
W.	NULL
F.	NULL
C.	NULL
1988	NULL
.	NULL

The	NULL
immunobiology	NULL
of	NULL
vitamin	NULL
D.	NULL
Immunol	NULL
.	NULL

Today	NULL
.	NULL

9:54-58	NULL
.	NULL

3	NULL
.	NULL

Mason	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
T.	NULL
Frankel	NULL
,	NULL
Y.	NULL
L.	NULL
Chan	NULL
,	NULL
D.	NULL
Lissner	NULL
,	NULL
and	NULL
S.	NULL
Posen	NULL
.	NULL

1984	NULL
.	NULL

Vitamin	NULL
D	NULL
conversion	NULL
by	NULL
sarcoid	NULL
lymph	NULL
node	NULL
homogenate	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

100:59-61	NULL
.	NULL

4	NULL
.	NULL

Clavel	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Garabedian	NULL
,	NULL
C.	NULL
Tau	NULL
,	NULL
and	NULL
J.	NULL
Orgiazzi	NULL
.	NULL

1987	NULL
.	NULL

Extrarenal	NULL
synthesis	NULL
of	NULL
calcitriol	NULL
in	NULL
sarcoidosis	NULL
.	NULL

Presse	NULL
Med	NULL
.	NULL

16	NULL
:	NULL
107-110	NULL
.	NULL

5	NULL
.	NULL

Cadranel	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
J.	NULL
Hance	NULL
,	NULL
B.	NULL
Milleron	NULL
,	NULL
F.	NULL
Paillard	NULL
,	NULL
G.	NULL
Akoun	NULL
,	NULL
and	NULL
M.	NULL
Garabedian	NULL
.	NULL

1988	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolism	NULL
in	NULL
tuberculosis	NULL
:	NULL
production	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
cells	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
and	NULL
the	NULL
role	NULL
of	NULL
this	NULL
metabolite	NULL
in	NULL
calcium	NULL
homeostasis	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

138:984-989	NULL
.	NULL

6	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
O.	NULL
P.	NULL
Sharma	NULL
,	NULL
M.	NULL
A.	NULL
Gacad	NULL
,	NULL
and	NULL
F.	NULL
R.	NULL
Singer	NULL
.	NULL

1983	NULL
.	NULL

Metabolism	NULL
of	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
by	NULL
cultured	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
in	NULL
sarcoidosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

72:1856-1860	NULL
.	NULL

7	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gacad	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
1-hy-droxylation	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
sterols	NULL
by	NULL
cultured	NULL
alveolar	NULL
macrophages	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161:755-765	NULL
.	NULL

8	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
F.	NULL
R.	NULL
Singer	NULL
,	NULL
M.	NULL
A.	NULL
Gacad	NULL
,	NULL
O.	NULL
P.	NULL
Sharma	NULL
,	NULL
M.	NULL
J.	NULL
Hayes	NULL
,	NULL
P.	NULL
Vouros	NULL
,	NULL
and	NULL
M.	NULL
Frholick	NULL
.	NULL

1985	NULL
.	NULL

Isolation	NULL
and	NULL
structural	NULL
identification	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
produced	NULL
by	NULL
cultured	NULL
alveolar	NULL
macrophages	NULL
in	NULL
sarcoidosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

&	NULL
Metab	NULL
.	NULL

60:960-966	NULL
.	NULL

9	NULL
.	NULL

Reichel	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
P.	NULL
Koeffler	NULL
,	NULL
R.	NULL
Barbers	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Norman	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
production	NULL
by	NULL
cultured	NULL
alveolar	NULL
macrophages	NULL
from	NULL
normal	NULL
human	NULL
donors	NULL
and	NULL
from	NULL
patients	NULL
with	NULL
pulmonary	NULL
sarcoidosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

&	NULL
Metab	NULL
.	NULL

65:1201-1209	NULL
.	NULL

10	NULL
.	NULL

Lecossier	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Valeyre	NULL
,	NULL
A.	NULL
Loiseau	NULL
,	NULL
J.	NULL
P.	NULL
Battesti	NULL
,	NULL
P.	NULL
Soler	NULL
,	NULL
and	NULL
A.	NULL
Hance	NULL
.	NULL

1988	NULL
.	NULL

T-lymphocytes	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
from	NULL
normal	NULL
subjects	NULL
and	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
are	NULL
refractory	NULL
to	NULL
proliferative	NULL
signals	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

137:592-599	NULL
.	NULL

11	NULL
.	NULL

Julius	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
E.	NULL
Simpson	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

A	NULL
rapid	NULL
method	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
functional	NULL
thymus-derived	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

3:645-653	NULL
.	NULL

12	NULL
.	NULL

Kumagai	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Itoh	NULL
,	NULL
S.	NULL
Hinuma	NULL
,	NULL
and	NULL
S.	NULL
Tada	NULL
.	NULL

1979	NULL
.	NULL

Pretreat-ment	NULL
of	NULL
plastic	NULL
petri	NULL
dishes	NULL
with	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

A	NULL
simple	NULL
method	NULL
for	NULL
macrophage	NULL
isolation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

29:17-25	NULL
.	NULL

13	NULL
.	NULL

Parks	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
V.	NULL
M.	NULL
Bryan	NULL
,	NULL
V.	NULL
R.	NULL
Oi	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1979	NULL
.	NULL

Antigen	NULL
specific	NULL
identification	NULL
and	NULL
cloning	NULL
of	NULL
hybridomas	NULL
with	NULL
a	NULL
fluorescence	NULL
activated	NULL
cell	NULL
sorter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

76:1962-1966	NULL
.	NULL

14	NULL
.	NULL

Shepard	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
R.	NULL
L.	NULL
Horts	NULL
,	NULL
A.	NULL
J.	NULL
Hamstra	NULL
,	NULL
and	NULL
H.	NULL
F.	NULL
Deluca	NULL
.	NULL

1979	NULL
.	NULL

Determination	NULL
of	NULL
vitamin	NULL
D	NULL
and	NULL
its	NULL
metabolites	NULL
in	NULL
plasma	NULL
from	NULL
normal	NULL
and	NULL
anephric	NULL
man	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

182:55-69	NULL
.	NULL

15	NULL
.	NULL

De	NULL
Lean	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
J.	NULL
Munson	NULL
,	NULL
and	NULL
D.	NULL
Rodbard	NULL
.	NULL

1978	NULL
.	NULL

Simultaneous	NULL
analysis	NULL
of	NULL
families	NULL
of	NULL
sigmoidal	NULL
curves	NULL
:	NULL
application	NULL
to	NULL
bioassay	NULL
,	NULL
radioligand	NULL
assay	NULL
,	NULL
and	NULL
physiological	NULL
dose	NULL
response	NULL
curves	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

235	NULL
:	NULL
E97-102	NULL
.	NULL

16	NULL
.	NULL

Cohen	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
K.	NULL
Gray	NULL
.	NULL

1984	NULL
.	NULL

Phagocytic	NULL
cells	NULL
metabolize	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:7538-7541	NULL
.	NULL

17	NULL
.	NULL

Mayer	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
E.	NULL
Bishop	NULL
,	NULL
N.	NULL
Onhuma	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Norman	NULL
.	NULL

1983	NULL
.	NULL

Biological	NULL
assessment	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
metabolites	NULL
1,25-dihydroxy-24-oxo-vitamin	NULL
D	NULL
;	NULL
and	NULL
1,23,25-trihydroxy-24-o0xo-vitamin	NULL
D	NULL
;	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

1-676	NULL
.	NULL

18	NULL
.	NULL

Napoli	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
L.	NULL
Sommerfeld	NULL
,	NULL
and	NULL
B.	NULL
C.	NULL
Pramanik	NULL
.	NULL

1983	NULL
.	NULL

19-nor-10-ketovitamin	NULL
D	NULL
derivatives	NULL
.	NULL

Biochemistry	NULL
.	NULL

22:3636-3640	NULL
.	NULL

19	NULL
.	NULL

Breslau	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
J.	NULL
L.	NULL
McGuire	NULL
,	NULL
J.	NULL
E.	NULL
Zerwekh	NULL
,	NULL
E.	NULL
P.	NULL
Frenkel	NULL
,	NULL
and	NULL
C.	NULL
Y.	NULL
C.	NULL
Pak	NULL
.	NULL

1984	NULL
.	NULL

Hypercalcemia	NULL
associated	NULL
with	NULL
increased	NULL
serum	NULL
calcitriol	NULL
levels	NULL
in	NULL
three	NULL
patients	NULL
with	NULL
lymphoma	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

100:1-7	NULL
.	NULL

20	NULL
.	NULL

Fetchik	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
D.	NULL
R.	NULL
Bertolini	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
S.	NULL
T.	NULL
Weintraub	NULL
,	NULL
G.	NULL
R.	NULL
Mundy	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Dunn	NULL
.	NULL

1986	NULL
.	NULL

Production	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
lymphotrophic	NULL
virus-l-transformed	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

78:592-596	NULL
.	NULL

21	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
H.	NULL
Reichel	NULL
,	NULL
J.	NULL
E.	NULL
Bishop	NULL
,	NULL
and	NULL
A.	NULL
W.	NULL
Norman	NULL
.	NULL

1985.	NULL
y-Interferon	NULL
stimulates	NULL
production	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
by	NULL
normal	NULL
human	NULL
macrophages	NULL
.	NULL

Biockem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

127:596-603	NULL
.	NULL

22	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
R.	NULL
L.	NULL
Modlin	NULL
,	NULL
M.	NULL
M.	NULL
Diz	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Barnes	NULL
.	NULL

1989	NULL
.	NULL

Potentiation	NULL
of	NULL
the	NULL
macrophage	NULL
25-hydroxyvitamin	NULL
D-1-hydroxyla-tion	NULL
reaction	NULL
by	NULL
human	NULL
tuberculosis	NULL
pleural	NULL
effusion	NULL
fluid	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

&	NULL
Metab	NULL
.	NULL

69:457-460	NULL
.	NULL

23	NULL
.	NULL

Hance	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
S.	NULL
Douches	NULL
,	NULL
R.	NULL
J.	NULL
Winchester	NULL
,	NULL
V.	NULL
J.	NULL
Ferrans	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Crystal	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
mononuclear	NULL
phagocyte	NULL
subpopulations	NULL
in	NULL
the	NULL
human	NULL
lung	NULL
by	NULL
using	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
changes	NULL
in	NULL
alveolar	NULL
macrophage	NULL
phenotype	NULL
associated	NULL
with	NULL
pulmonary	NULL
sarcoidosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:284-292	NULL
.	NULL

24	NULL
.	NULL

Rook	NULL
,	NULL
G.	NULL
A.	NULL
W.	NULL
,	NULL
J.	NULL
Taverne	NULL
,	NULL
C.	NULL
Leveton	NULL
,	NULL
and	NULL
J.	NULL
Steele	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
role	NULL
of	NULL
gamma-interferon	NULL
,	NULL
vitamin	NULL
D	NULL
;	NULL
metabolites	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
tuberculosis	NULL
.	NULL

Immunology	NULL
.	NULL

62:229-234	NULL
.	NULL

25	NULL
.	NULL

Rook	NULL
,	NULL
G.	NULL
A.	NULL
W.	NULL
1988	NULL
.	NULL

The	NULL
role	NULL
of	NULL
vitamin	NULL
D	NULL
in	NULL
tuberculosis	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

138:768-770	NULL
.	NULL

26	NULL
.	NULL

Rook	NULL
,	NULL
G.	NULL
A.	NULL
W.	NULL
,	NULL
J.	NULL
Steele	NULL
,	NULL
L.	NULL
Fraher	NULL
,	NULL
S.	NULL
Barker	NULL
,	NULL
R.	NULL
Karmali	NULL
,	NULL
J.	NULL
O'Riordan	NULL
,	NULL
and	NULL
J.	NULL
Stanford	NULL
.	NULL

1986	NULL
.	NULL

Vitamin	NULL
D	NULL
;	NULL
,	NULL
gamma	NULL
interferon	NULL
,	NULL
and	NULL
control	NULL
of	NULL
proliferation	NULL
of	NULL
Mycobacterium	NULL
tuberculosis	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

Immunology	NULL
.	NULL

57:159-163	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Production	NULL
by	NULL
Lung	NULL
T	NULL
Lymphocytes	NULL
_	NULL
1§93	NULL

